icon-folder.gif   Conference Reports for NATAP  
 
  IDSA
ID Week 2026
October 21-24
Washington, DC

Back grey_arrow_rt.gif
 
 
 
Modeling Confirms Islatravir 0.25 Administered Daily
Has No Adverse Effect on Total Lymphocyte or CD4+ T-Cell Counts in PLWH
 
 
 

1023251

1023252